ALINA GODOVSKA: Open Payments
NPI 1811529423 · NEW PROVIDENCE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$183 in 10 payments from 5 companies in 2025. Trend: 2023 $295 · 2024 $478 · 2025 $183
Food & beverage: $183
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $65 |
| Optinose US, Inc. | 2 | $44 |
| GENZYME CORPORATION | 2 | $32 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Hikma Pharmaceuticals USA | 1 | $17 |
Products named: NUCALA, Xhance, DUPIXENT, INSPIRE, Ryaltris.
Industry payments across NJ — which companies pay providers there.
